L251-1098 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide

L251-1098 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide
L251-1098 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L251-1098
2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L251-1098

Molecular Formula

C24H31FN4O3S (C24 H31 FN4 O3 S)

Compound Name

2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide

IUPAC name

2-{1-[2-(4-fluorophenyl)-4-methyl-13-thiazole-5-carbonyl]piperidin-4-yl}-N-[2-(morpholin-4-yl)ethyl]acetamide

SMILES

Cc1c(C(N2CCC(CC(NCCN3CCOCC3)=O)CC2)=O)sc(-c(cc2)ccc2F)n1

InChI

InChI=1S/C24H31FN4O3S/c1-17-22(33-23(27-17)19-2-4-20(25)5-3-19)24(31)29-9-6-18(7-10-29)16-21(30)26-8-11-28-12-14-32-15-13-28/h2-5,18H,6-16H2,1H3,(H,26,30)

InChI Key

JORIDWJBVGWHQX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27238173

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.6

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.434

Distribution Coefficient, logD

2.358

Water Solubility, LogSw

-2.73

Polar Surface Area

63.130

Acid Dissociation Constant (pKa)

13.60

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

L251-1098 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

MCL1 Targeted Library (12200 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L251-1098 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L251-1098?
Check Price and Availability of L251-1098, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L251-1098 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L251-1098
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L251-1098
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L251-1098 available by request